Literature DB >> 18715272

Coexistence of Creutzfeldt-Jakob disease, Lewy body disease, and Alzheimer's disease pathology: an autopsy case showing typical clinical features of Creutzfeldt-Jakob disease.

Takashi Haraguchi1, Seishi Terada, Hideki Ishizu, Kenichi Sakai, Yasuyuki Tanabe, Taiji Nagai, Hiroshi Takata, Keigo Nobukuni, Yuetsu Ihara, Tetsuyuki Kitamoto, Shigetoshi Kuroda.   

Abstract

We report here an autopsy case of sporadic Creutzfeldt-Jakob disease (CJD) without hereditary burden and with a clinical course typical of sporadic CJD. A 77-year old man developed memory disturbance, followed by gait disturbance and myoclonus. He died of bronchopneumonia 5 months after the disease onset. Post-mortem examination revealed neuronal loss, astrocytosis, and patchy spongiosis in the cerebral cortex and lenticular nuclei. Synaptic-type deposits of prion protein were present in the cerebral cortex. Additionally, Lewy bodies were observed in the cerebral cortex and substantia nigra. Furthermore, senile plaques compatible with definite Alzheimer's disease according to Consortium to Establish a Registry for Alzheimer's disease criteria and neurofibrillary changes of the limbic system consistent with Braak stage IV were found. Based on a review of the published literature, this autopsy case is very rare, and we suppose that the incidence of CJD accompanied by Lewy body disease and Alzheimer's disease is very low.

Entities:  

Mesh:

Year:  2009        PMID: 18715272     DOI: 10.1111/j.1440-1789.2008.00964.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  10 in total

1.  Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.

Authors:  Rodrigo Morales; Lisbell D Estrada; Rodrigo Diaz-Espinoza; Diego Morales-Scheihing; Maria C Jara; Joaquin Castilla; Claudio Soto
Journal:  J Neurosci       Date:  2010-03-31       Impact factor: 6.167

2.  Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype.

Authors:  Suman Jayadev; David Nochlin; Parvoneh Poorkaj; Ellen J Steinbart; James A Mastrianni; Thomas J Montine; Bernardino Ghetti; Gerard D Schellenberg; Thomas D Bird; James B Leverenz
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

Review 3.  Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases.

Authors:  Anna Villar-Piqué; Matthias Schmitz; Niccolò Candelise; Salvador Ventura; Franc Llorens; Inga Zerr
Journal:  Mol Neurobiol       Date:  2018-02-10       Impact factor: 5.590

Review 4.  Immunomodulation for prion and prion-related diseases.

Authors:  Thomas Wisniewski; Fernando Goñi
Journal:  Expert Rev Vaccines       Date:  2010-12       Impact factor: 5.217

5.  Unusual features of Creutzfeldt-Jakob disease followed-up in a memory clinic.

Authors:  Agnès Jacquin; Vincent Deramecourt; Serge Bakchine; Claude-Alain Maurage; Florence Pasquier
Journal:  J Neurol       Date:  2014-01-30       Impact factor: 4.849

6.  Translation of the prion protein mRNA is robust in astrocytes but does not amplify during reactive astrocytosis in the mouse brain.

Authors:  Walker S Jackson; Clemens Krost; Andrew W Borkowski; Lech Kaczmarczyk
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

7.  Parkinson's disease with a typical clinical course of 17 years overlapped by Creutzfeldt-Jakob disease: an autopsy case report.

Authors:  Shin-Ichiro Kubo; Tomoyasu Matsubara; Takeshi Taguchi; Renpei Sengoku; Atsuko Takeuchi; Yuko Saito
Journal:  BMC Neurol       Date:  2021-12-10       Impact factor: 2.474

8.  α-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication.

Authors:  Suzana Aulić; Lara Masperone; Joanna Narkiewicz; Elisa Isopi; Edoardo Bistaffa; Elena Ambrosetti; Beatrice Pastore; Elena De Cecco; Denis Scaini; Paola Zago; Fabio Moda; Fabrizio Tagliavini; Giuseppe Legname
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

9.  High Incidence of Sporadic Creutzfeldt-Jakob Disease in Slovenia in 2015: A Case Series.

Authors:  Tomaž Rus; Bogdan Lorber; Maja Trošt; Srečko Dobrecovič; Nuška Čakš Jager; Mara Popović; Milica G Kramberger
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2018-02-08

10.  Understanding Creutzfeldt-Jackob disease from a viewpoint of amyloidogenic evolvability.

Authors:  Makoto Hashimoto; Gilbert Ho; Yoshiki Takamatsu; Ryoko Wada; Shuei Sugama; Masaaki Waragai; Eliezer Masliah; Takato Takenouchi
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.